Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00773253 · ClinicalTrials.gov registry record · Phase 4

Botox for Cervical Dystonia Following EMG Mapping

A Phase 4 study, sponsored by University of California, San Francisco.

Completed
Registry status
Phase 4
Development phase
10
Enrollment target

NCT00773253: Completed Phase 4 study, sponsored by University of California, San Francisco.

NCT00773253 is a Phase 4 study that has completed, run by University of California, San Francisco. The registered enrollment target is 10 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00773253, a Phase 4 study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
Phase 4
Development phase
10 participants
Enrollment target

Study Summary

The purpose of this study is to determine how to improve treatment of patients with cervical dystonia who have not been helped with standard Botox injections. This study is for patients with cervical dystonia who have not benefited from treatment with Botox using conventional "single lead electromyographic (EMG) techniques" for injection. The study aim is to see if these patients may have significantly more benefit if their Botox is injected into muscles that have been chosen with a multi-channel EMG mapping study of the neck prior to Botox injection.

Interventions

  • DRUG Botulinum toxin A

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2008-04
Est. Completion 2011-01
Phase Phase 4

What the finished NCT00773253 record still lists

NCT00773253 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Botulinum toxin A is the first listed.

NCT00773253 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00773253 about?

NCT00773253 is a clinical study titled "Botox for Cervical Dystonia Following EMG Mapping". The purpose of this study is to determine how to improve treatment of patients with cervical dystonia who have not been helped with standard Botox injections. This study is for patients with cervical dystonia who have not benefited from treatment with Botox using conventional "single lead electromyo...

What is the current status of trial NCT00773253?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2008-04. Estimated completion is 2011-01.

What interventions are being tested in trial NCT00773253?

The interventions under investigation include: Botulinum toxin A (DRUG).

Who is sponsoring clinical trial NCT00773253?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00773253's enrollment target sits among peer trials

10 1940th of 2000 higher than 33 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00773253, the US trial registry maintained by the National Library of Medicine. NCT00773253 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.